Nutrition: Oncology Nutrition Support

Optimal nutrition is a cornerstone of cancer care, directly influencing your ability to tolerate treatment, manage side effects, and preserve physical function. Malnutrition can lead to dose reductions, treatment delays, and increased hospitalization rates, ultimately impacting survival and quality of life.

The Multifaceted Impact of Cancer and Its Treatment on Nutrition

Cancer itself and its treatments create a perfect storm for nutritional decline. The tumor can alter metabolism, leading to a hypermetabolic state where the body burns calories inefficiently. Simultaneously, common side effects directly interfere with eating. Nausea and vomiting, often triggered by chemotherapy, create a strong aversion to food. Mucositis, the painful inflammation and ulceration of the digestive tract lining, can make chewing and swallowing agonizing. Taste changes (dysgeusia) and anorexia (loss of appetite) further diminish interest in food, often making previously enjoyed items taste metallic or bland. These factors collectively drive inadequate intake, which, when combined with the metabolic dysregulation of cancer, can precipitate cancer cachexia. This is a complex syndrome characterized by progressive, involuntary weight loss due to the loss of both fat and muscle mass, which is distinct from simple starvation and is a major contributor to morbidity and mortality.

Systematic Nutritional Assessment: Identifying Risk and Severity

Before intervening, you must accurately gauge the nutritional problem. Registered dietitians conduct a thorough assessment that goes beyond the scale. Evaluating weight loss severity is critical; unintentional loss of more than 5% of usual body weight in one month or 10% in six months is a significant red flag. Assessment tools like the Patient-Generated Subjective Global Assessment (PG-SGA) are gold standards, integrating weight history, symptoms, functional capacity, and physical exam findings. For instance, a patient reporting a 7% weight loss over two months, combined with severe mucositis and reduced food intake, would be scored as severely malnourished, triggering immediate and aggressive intervention. This assessment establishes a baseline and helps monitor progression or improvement over time.

Implementing Targeted Nutritional Support Strategies

Interventions are tailored to the patient's ability to eat, digest, and absorb nutrients. The first line of defense involves calorie-dense strategies to maximize intake from ordinary food. This includes eating small, frequent meals; adding healthy fats like avocado or olive oil; and using fortified milk or gravies. When oral intake is insufficient but the gut is functional, oral nutritional supplements (ONS)—high-protein, high-calorie shakes—are introduced.

If oral intake remains inadequate, specialized nutrition support is required. Enteral nutrition (EN), or tube feeding, is preferred whenever possible, as it maintains gut function and integrity. A nasogastric or gastrostomy tube may be placed to deliver formula directly to the stomach or small intestine. Parenteral nutrition (PN) is reserved for when the gastrointestinal tract is non-functional, such as in cases of severe ileus or bowel obstruction. PN involves intravenous infusion of a sterile solution containing glucose, amino acids, lipids, vitamins, and minerals. The decision between EN and PN hinges on gut function, with EN being safer and associated with fewer infectious complications.

The Role of Immunonutrition and Metabolic Modulation

Beyond calories and protein, specific nutrients can modulate the immune and inflammatory response. Immunonutrition refers to the therapeutic use of pharmacologically active nutrients like arginine, omega-3 fatty acids, and nucleotides. In surgical oncology patients, formulas enriched with these components have been shown to reduce postoperative infection rates and length of hospital stay. For example, omega-3 fatty acids (e.g., from fish oil) can help counter the inflammatory processes that drive cachexia. While not a standalone treatment, immunonutrition is a supportive strategy integrated into nutritional care plans, particularly in the perioperative period or for patients with advanced cachexia, to help improve immune competence and potentially mitigate treatment-related toxicity.

Nutritional Recovery and Sustenance in Survivorship

The end of active treatment does not signal the end of nutritional challenges. The survivorship phase focuses on nutritional recovery, restoring healthy body composition, and managing long-term side effects that affect eating. Goals shift toward a balanced, predominantly plant-based diet rich in phytochemicals to support overall health and potentially reduce recurrence risk. Continued monitoring is essential to prevent the progression of residual cancer cachexia or to address lingering taste changes and fatigue. Nutritional counseling during survivorship empowers patients to rebuild strength, manage weight healthily, and adopt dietary patterns that support long-term well-being and quality of life.

Common Pitfalls

1. Delaying Specialist Referral: Relying solely on general encouragement to "eat more" without a formal dietitian assessment allows malnutrition to worsen. Correction: Integrate routine nutritional screening at diagnosis and throughout treatment, with automatic referral to a registered dietitian for any significant weight loss or symptom burden.
2. Overlooking Patient-Specific Barriers: Prescribing a high-protein diet without addressing severe taste changes or mucositis is ineffective. Correction: First manage symptoms: recommend cold, soft foods for mucositis; suggest using plastic utensils and marinades to combat metallic taste changes before focusing on dietary content.
3. Misapplying Parenteral Nutrition: Using PN when the gut is functional increases risk for bloodstream infections and liver complications. Correction: Adhere to the principle "if the gut works, use it." Reserve PN for clear indications like intestinal failure or prolonged ileus where EN is not feasible.
4. Neglecting Follow-up in Survivorship: Assuming nutritional issues resolve after treatment ends can leave patients struggling. Correction: Schedule post-treatment nutritional follow-ups to assess recovery, provide guidance for a health-promoting diet, and address any persistent gastrointestinal or metabolic issues.

Summary

• Oncology nutrition is proactive management of treatment side effects like nausea, mucositis, and anorexia to prevent and treat cancer-related malnutrition and cachexia.
• Comprehensive assessment, including tracking weight loss severity, is essential to triage patients and guide the intensity of intervention, from calorie-dense oral strategies to enteral or parenteral nutrition support.
• Immunonutrition utilizes specific nutrients to modulate inflammation and immune function, serving as a valuable adjunct in surgical and cachectic patients.
• Nutritional care extends into survivorship, focusing on recovery of body composition and the adoption of long-term, health-supportive dietary patterns.
• Effective support requires a patient-centered approach that addresses individual symptoms and barriers, prioritizes enteral over parenteral feeding when possible, and ensures continuity of care beyond active treatment.